Vimarsana
Biggest News Aggregation in the World

Page 10 - Biomedical Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biomedical Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biomedical Technology Today - Breaking & Trending Today

Group urges Katsina gov to establish varsity in Malumfashi - Vimarsana News

Group urges Katsina gov to establish varsity in Malumfashi

The amalgamation of Malumfashi Students Old Boys Union and the concerned Malumfashi Progressive Group have jointly called on Katsina State

Samsung Biologics Unveils $920 Million Manufacturing Deals for Pfizer - Vimarsana News

Samsung Biologics Unveils $920 Million Manufacturing Deals for Pfizer

South Korea's Samsung Biologics announced on Tuesday two deals with Pfizer worth around a combined 1.2 trillion won ($921.38 million) to manufacture products for the US pharmaceutical giant.

Inaugural Merkin Prize in Biomedical Technology awarded to Dr. Marvin Caruthers for developing technology that efficiently synthesizes DNA - Vimarsana News

Inaugural Merkin Prize in Biomedical Technology awarded to Dr. Marvin Caruthers for developing technology that efficiently synthesizes DNA

/PRNewswire/ -- Dr. Marvin H. Caruthers of the University of Colorado, Boulder, has won the inaugural Richard N. Merkin Prize in Biomedical Technology for...

Oral Drug for Brain Tumor Could Change Treatment Landscape - Vimarsana News

Oral Drug for Brain Tumor Could Change Treatment Landscape

In patients with gliomas bearing IDH1/2 mutations, the brain barrier-crossing oral drug vorasidenib kept tumors at bay, and could be used instead of more toxic chemotherapies and radiation.

Pfizer, Moderna Hit With Patent Lawsuits Over COVID Vaccines - Vimarsana News

Pfizer, Moderna Hit With Patent Lawsuits Over COVID Vaccines

Biotech company Alnylam Pharmaceuticals filed new lawsuits against Pfizer Inc and Moderna Inc in Delaware federal court, again claiming that the companies' COVID-19 vaccines infringe its patents.